Acute liver failure

N K Arora1, P Mathur, A Ahuja

  • 1Division of Pediatric Gastroenterology, Hepatology & Nutrition, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. nkmanan@hotmail.com

Insights

Acute liver failure in children, often caused by viruses like Hepatitis A (HAV) and E (HEV), has high mortality. Early recognition and supportive care are crucial, but outcomes remain poor, highlighting the need for advanced treatments.

Area of Science:

  • Pediatric Hepatology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Acute liver failure (ALF) in children presents a significant mortality risk.
  • Hepatotropic viruses, specifically Hepatitis A virus (HAV) and Hepatitis E virus (HEV), are primary etiological agents in this population.
  • Effective management hinges on timely diagnosis and intervention.

Purpose of the Study:

  • To emphasize the critical need for early identification of subtle signs of ALF in pediatric patients.
  • To underscore the importance of prompt supportive therapy and complication management.
  • To evaluate the current therapeutic outcomes and future treatment possibilities.

Main Methods:

  • Review of clinical presentation and outcomes of pediatric ALF cases.
  • Analysis of etiological factors, focusing on viral causes (HAV, HEV).
  • Assessment of current intensive care management strategies and their efficacy.

Main Results:

  • High mortality rates (40-60%) persist despite advanced intensive care.
  • Water-borne hepatotropic viruses (HAV, HEV) are identified as major contributors.
  • Early recognition and management of complications are vital but insufficient to overcome the high mortality.

Conclusions:

  • Early detection and supportive care are paramount in managing pediatric ALF.
  • Current intensive care measures yield limited survival rates, necessitating alternative strategies.
  • Liver transplantation is proposed as a potentially life-saving option upon its availability in India.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...